Cargando…
Thioredoxin mitigates H(2)O(2)‐induced inhibition of myogenic differentiation of rat bone marrow mesenchymal stem cells by enhancing AKT activation
Thioredoxin (Trx) is a hydrogen acceptor of ribonucleotide reductase and a regulator of some enzymes and receptors. It has been previously shown that significantly elevated levels of Trx expression are associated with the osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs), but...
Autores principales: | Liu, Meiling, Li, Xianglu, Zhou, Changlin, Wang, Manfeng, Wang, Hongzhi, Ding, Haifeng, Cheng, Luyang, Gan, Lu, Wu, Xiaowei, Du, Zhimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193161/ https://www.ncbi.nlm.nih.gov/pubmed/32160414 http://dx.doi.org/10.1002/2211-5463.12835 |
Ejemplares similares
-
Moringa oleifera leaf extracts protect BMSC osteogenic induction following peroxidative damage by activating the PI3K/Akt/Foxo1 pathway
por: Liu, Meiling, et al.
Publicado: (2021) -
Bone Marrow-Derived Mesenchymal Cell Differentiation toward Myogenic Lineages: Facts and Perspectives
por: Galli, Daniela, et al.
Publicado: (2014) -
Essential Role of Thioredoxin 2 in Mitigating Oxidative Stress in Retinal Epithelial Cells
por: Sugano, Eriko, et al.
Publicado: (2013) -
Thioredoxin-1 Protects Bone Marrow-Derived Mesenchymal Stromal Cells from Hyperoxia-Induced Injury In Vitro
por: Zhang, Lei, et al.
Publicado: (2018) -
Thioredoxin mitigates radiation-induced hematopoietic stem cell injury in mice
por: Sundaramoorthy, Pasupathi, et al.
Publicado: (2017)